CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment-Reference-Cited by-同舟云学术

CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment

Published:2020-01 Issue:1 Volume:6 Page:
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:A&D Transl Res & Clin Interv

Author:

Brisson Mélanie¹,Brodeur Catherine²,Létourneau‐Guillon Laurent³,Masellis Mario⁴,Stoessl Jon⁵,Tamm Alex⁶,Zukotynski Katherine⁷,Ismail Zahinoor⁸,Gauthier Serge⁹,Rosa‐Neto Pedro⁹¹⁰,Soucy Jean‐Paul³¹⁰¹¹

Affiliation:

1. Centre hospitalier de l'université de Québec Quebec City Canada

2. Institut universiatire de gériatrie de Montréal Montreal Canada

3. Centre hospitalier de l'université de Montréal Montreal Canada

4. Sunnybrook Health Sciences Centre Toronto Canada

5. Vancouver Coastal Health, University of British‐Columbia Vancouver Canada

6. University of Alberta Edmonton Canada

7. McMaster University Hamilton Canada

8. Department of Psychiatry, Hotchkiss Brain Institute and O'Brien Institute for Public Health University of Calgary Calgary Canada

9. McGill Center for Studies in Aging Canada

10. McConnell Brain Imaging Centre, Montreal Neurological Institute Montreal Canada

11. PERFORM Center, Concordia University Montreal Canada

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/trc2.12098

Reference168 articles.

1. Canadian consensus conference on the assessment of dementia. Assessing dementia: the Canadian Consensus;Organizing Committee;CMAJ,1991

2. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia;Patterson C;CMAJ,1999

3. Diagnosis and treatment of dementia: Introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia

4. Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)

5. Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PET Imaging in Dementia: Mini-Review and Canadian Perspective for Clinical Use;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2024-03-04

2. Neuroimaging in Clinical Geriatric Psychiatry;Geriatric Psychiatry;2024

3. Major or Mild Neurocognitive Disorder Due to Alzheimer Disease;Geriatric Psychiatry;2024

4. Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer’s disease?;Frontiers in Aging Neuroscience;2023-04-18

5. Neuroimaging modalities in the detection of Alzheimer's disease-associated biomarkers;Psychoradiology;2023-03